期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

M型磷脂酶A2受体及其抗体在特发性膜性肾病诊治中的作用 被引量：1

Role of M-type phospholipase A2 receptor and its antibody in diagnosis and treatment of idiopathic membranous nephropathy
下载PDF
导出
摘要 M型磷脂酶A2受体(M-Type phospholipase A2receptor,PLA2R)作为特发性膜性肾病(Idiopathic membranous nephropathy,IMN)的一种特异度自身抗体已被广泛证实,为IMN发病机制的研究开辟了新的思路。大量的临床资料表明,PLA2R及其抗体在膜性肾病的发病过程中起重要作用,且与疾病的活动性、严重程度及预后相关,甚至可以预测疾病复发,指导治疗时机的选择。本文对PLA2R及其抗体在IMN诊断和治疗过程中的应用价值进行综述。 M-type phospholipase A2 receptor （PLA2R） has been widely confirmed as a specific auto-antibody for Idiopathic membranous nephropathy （IMN）, which has opened up a new train of thought the pathogenesis of IMN . A large number of clinical data indicate that PLA2R and its antibody play an important role in the pathogenesis of IMN, and are related to the activity, severity and prognosis of the disease. It can even predict disease recurrence and guide the timing of treatment. This article reviews the application value of PLA2R and its antibody in the diagnosis and treatment of IMN.
作者 卢玥 李绍梅 Lu Yue;Li Shaomei(Department of Nephrology,The Second Hospital of Hebei Medical University,Shijiazhuang 050000,China)
机构地区 河北医科大学第二医院肾内科
出处 《临床荟萃》 CAS 2018年第10期839-845,共7页 Clinical Focus
关键词 肾小球肾炎 膜性 M型磷脂酶A2受体 抗M型磷脂酶A2受体抗体 glomerulonephritis membranous M-type phospholipase A2 receptor anti-PLA2R
分类号 R692.31 [医药卫生—泌尿科学]
  • 相关文献

参考文献3

二级参考文献38

  • 1全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量：706
  • 2Nachman PH, Jennette JC, Falk RJ. Membranous Glomerul-pathy[M]//Brenner BM. Brenner and Reetor's The Kidney. 9th ed. Boston. USA: Saunders, 2012, 1121-1131.
  • 3Li IS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China : analysis basedon 13,519 renal biopsies [J]. Kidney Int, 2004, 66(3): 920-923.
  • 4MoharnmadReza Ardalan, All Ghafari, Fatemeh Hamzavi, et al. Anti-phospholipase A2 receptor antibody in idiopathic membrano us nephropathy: a report from Iranian population [J].Journal of Nephropathology, 2013, 2(4): 241-248.
  • 5Sui WG, He HY, Yah Q, et al. ChlP-seq analysis of hist one H3K9 trimethylation in peripheral blood mononuclear cells of mere hranous nephropathy patientsBrazilian [J].Journal of Medical and Biological Research, 2014, 47(1): 42-49.
  • 6All Nayerl, Arif Asif. Idiopathic membranous nephropathy and anti-phospholipase A2 receptor antibodies Journal of Ne- phropathology[J]. Journal of Nephropathology, 2013, 2(4) : 214-216.
  • 7Hofstra JM, Beck LH, Beck DM, et al. Anti-phospholipase A receptor antibodies correlate with clinical status in idiopathic membranous nephropathy[J]. Clin J Am Soc Nephro, 2011, 6 (6) : 1286-1291.
  • 8Carlos R, Franco Palacios, John C Lieske, et al. Urine but not serum soluble urokinase receptor (suPAR) may identifycases of recurrent FSGS in kidney transplant candidates[J]. NIH-PA Author Manuseript, 2013, 96(4)I 394-399.
  • 9Myllymaki J, Honkanen T, Syrjanen J, et al. Uric acid corre- lates with the severity of histopathological parameters in IgA nephropathy[J].nephropathy Transplant, 2005, 20 (1) : 89- 95.
  • 10Debiec H, Martin L, Jouanneau C, et al. Autoantibod-ies spe- cific for the phospholipase A2 receptor in recur-rent and De Novomembranous nephropathy [J]. Am J transplant, 2011, 11(10) : 2144-2511.

共引文献28

同被引文献7

引证文献1

临床荟萃
2018年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部